Nyxoah S.A.
$2.86+1.78%(+$0.05)
TickerSpark Score
48/100
65
Valuation
35
Profitability
55
Growth
56
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NYXH research report →
52-Week Range2% of range
Low $2.72
Current $2.86
High $8.64
Companywww.nyxoah.com
Nyxoah S. A. , a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions.
- CEO
- Olivier Taelman
- IPO
- 2021
- Employees
- 183
- HQ
- Mont-Saint-Guibert, BE
Price Chart
-62.86% · this period
Valuation
- Market Cap
- $106.80M
- P/E
- -1.23
- P/S
- 5.63
- P/B
- 2.95
- EV/EBITDA
- -1.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 48.34%
- Op Margin
- -527.24%
- Net Margin
- -527.77%
- ROE
- -164.44%
- ROIC
- -116.24%
Growth & Income
- Revenue
- $10.02M · 121.63%
- Net Income
- $-90,085,000 · -52.08%
- EPS
- $-2.37 · -30.94%
- Op Income
- $-82,942,000
- FCF YoY
- -23.51%
Performance & Tape
- 52W High
- $8.64
- 52W Low
- $2.72
- 50D MA
- $3.12
- 200D MA
- $4.67
- Beta
- 1.58
- Avg Volume
- 52.69K
Get TickerSpark's AI analysis on NYXH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NYXH Coverage
We haven't published any research on NYXH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NYXH Report →